Parkinson Disease: evidence brief
Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 (capped at 1,000 of 2,379 matching trials) · https://research.opensourcemed.info/briefs/parkinson-disease.html
Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.
Medicines with registered trials
Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.
- BIA 9-1067 2 trials
- Entacapone 2 trials
- HER-096 2 trials
- Istradefylline 2 trials
- Levodopa 2 trials
- ND0611 (see NCT01103011) 2 trials
Non-drug approaches tested
Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.
- Transcranial brain stimulation (tDCS, TMS) 74 trials · 25 completed · 6 with results
- Psychotherapy, counselling and peer support 13 trials · 9 completed · 4 with results
- Aerobic and endurance exercise 39 trials · 20 completed · 3 with results
- Education, coaching and self-management 17 trials · 7 completed · 2 with results
- Physiotherapy and physical therapy 20 trials · 6 completed · 2 with results
- Peripheral electrical and electromagnetic stimulation 7 trials · 3 completed · 2 with results
Natural products (RepurpOS Moderate tier)
Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.
- Vitamin D3
- Creatine
- Coenzyme Q10
- Mucuna Pruriens
- D-Serine
Trials recruiting
Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.
- Prevent Cognitive Decline in GBA-associated Parkinson's Disease NCT07055087
- A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients. NCT07630545
- A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With… NCT06565195
- Mid-frontal Delta/Theta and Cognitive Control NCT06984757
- Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage NCT06993142
- Effectiveness of TeleVR App in Cognitive Decline and MCI Patients NCT06793735
What we don't know yet
Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.
- Other devices and digital tools: physical function and exercise capacity 13 trials, no results posted yet
- Neuromodulation and electrical stimulation: cognition 11 trials, no results posted yet